Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-05-010923
Filing Date
2005-03-14
Accepted
2005-03-14 19:15:37
Documents
1
Period of Report
2005-03-11

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4473
  Complete submission text file 0001104659-05-010923.txt   6302
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Issuer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 0907
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address C/O NEOPHARM INC 150 FIELD DRIVE STE 195 LAKE FOREST IL 60045 8472958678
HANSON ERICK E (Reporting) CIK: 0001230479 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12493 | Film No.: 05679745